182 related articles for article (PubMed ID: 24443980)
21. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
22. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
Toda I; Wickham LA; Sullivan DA
Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
[TBL] [Abstract][Full Text] [Related]
23. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
[TBL] [Abstract][Full Text] [Related]
24. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Sato EH; Ariga H; Sullivan DA
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2537-45. PubMed ID: 1634351
[TBL] [Abstract][Full Text] [Related]
25. Identification of candidate genes for Sjögren's syndrome using MRL/lpr mouse model of Sjögren's syndrome and cDNA microarray analysis.
Azuma T; Takei M; Yoshikawa T; Nagasugi Y; Kato M; Otsuka M; Shiraiwa H; Sugano S; Mitamura K; Sawada S; Masuho Y; Seki N
Immunol Lett; 2002 May; 81(3):171-6. PubMed ID: 11947921
[TBL] [Abstract][Full Text] [Related]
26. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
27. Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice.
Fujita H; Fujihara T; Takeuchi T; Saito I; Tsubota K
Adv Exp Med Biol; 1998; 438():941-8. PubMed ID: 9634991
[No Abstract] [Full Text] [Related]
28. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Jabs DA; Prendergast RA; Rorer EM; Hudson AP; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2567-71. PubMed ID: 11581200
[TBL] [Abstract][Full Text] [Related]
29. Detection of Grb-2-related adaptor protein gene (GRAP) and peptide molecule in salivary glands of MRL/lpr mice and patients with Sjögren's syndrome.
Shiraiwa H; Takei M; Yoshikawa T; Azuma T; Kato M; Mitamura K; Ueki T; Kida A; Horie T; Seki N; Sawada S
J Int Med Res; 2004; 32(3):284-91. PubMed ID: 15174222
[TBL] [Abstract][Full Text] [Related]
30. Impaired neurotransmission in lacrimal and salivary glands of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Adv Exp Med Biol; 2002; 506(Pt B):1023-8. PubMed ID: 12614026
[No Abstract] [Full Text] [Related]
31. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
32. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.
da Costa SR; Wu K; Veigh MM; Pidgeon M; Ding C; Schechter JE; Hamm-Alvarez SF
Exp Eye Res; 2006 Jan; 82(1):33-45. PubMed ID: 16005870
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model.
Killian M; Colaone F; Haumont P; Nicco C; Cerles O; Chouzenoux S; Cathébras P; Rochereau N; Chanut B; Thomas M; Laroche N; Forest F; Grouard-Vogel G; Batteux F; Paul S
Front Immunol; 2021; 12():666134. PubMed ID: 34867938
[TBL] [Abstract][Full Text] [Related]
34. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome.
Sato EH; Sullivan DA
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2632-42. PubMed ID: 8163351
[TBL] [Abstract][Full Text] [Related]
35. SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model.
Zhou WD; Yang HM; Wang Q; Su DY; Liu FA; Zhao M; Chen QH; Chen QX
Hum Reprod; 2010 Dec; 25(12):3110-6. PubMed ID: 20956267
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
37. Blueberry Leaf Extract Prevents Lacrimal Hyposecretion in Sjögren's Syndrome-like Model of Non-obese Diabetic Mice.
Ogawa K; Urata K; Maeda S; Ohno Y; Satoh K; Yamada Y; Suzuki Y; Koga Y; Sugamoto K; Kawaguchi M; Kunitake H; Nishiyama K; Goto YO; Nakayama T; Yamasaki M
In Vivo; 2023; 37(1):149-162. PubMed ID: 36593026
[TBL] [Abstract][Full Text] [Related]
38. Sjögren's syndrome in mice carrying the Ipr(cg) gene and the therapeutic efficacy of an immunosuppressive agent FK506.
Yang J; Shikata N; Yasuda T; Matsuzawa A; Tsubura A
Pathol Int; 1999 Feb; 49(2):133-40. PubMed ID: 10355966
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
40. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
